Our robust portfolio in blood cancers and solid tumors is comprised of first-of-its kind treatments and an advancing pipeline of more than 20 investigational ... |
Products ; ACTIGALL®. ursodiol, USP · Pronunciation. AK-tih-gaul ; ACTONEL®. risedronate sodium · Pronunciation. AK-toh-nel ; ACULAR LS®. ketorolac tromethamine ... |
At AbbVie, our mission is to have a remarkable impact on people's lives. We are passionate about advancing oncology research and development with an aim to ... |
Explore our Oncology space for the latest product information and AbbVie support for DLBCL, AML and CLL| This content is for UK healthcare professionals ... |
Its oncology products – Imbruvica (ibrutinib) and Venclexta (venetoclax) – target complex and difficult-to-treat cancers. The company's aesthetics portfolio ... |
28 мая 2024 г. · Today, our expansive oncology portfolio comprises of approved and investigational treatments for a wide range of blood and solid tumors. We are ... |
Oncology Careers at AbbVie · Blood Cancer Explained Series: How New Research is Addressing Unmet Needs · Blood Cancer Explained Series: Treatment Options After ... |
This AbbVie R&D oncology website focusing on science and cancer research is intended for the use of US Healthcare Professionals only. This includes information ... |
11 июн. 2024 г. · AbbVie's cancer drug portfolio is headlined by treatments for blood malignancies. Recently, though, the big drugmaker has made solid tumors a ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |